Nutex Health Reports Third Quarter 2026 Financial Performance and Outlook

Nutex Health: Q3 2026 Financial Performance

Nutex Health Inc., a physician-led healthcare services company, has announced its financial results for the third quarter of 2026. The company operates 28 hospital facilities across 12 states, focusing on primary care and population health management. The financial insights reveal a strong operational performance despite fluctuations in revenue.

Q3 Financial Highlights

For the three months ending September 30, 2026, Nutex Health reported a net income of $40.2 million, translating to a diluted earnings per share (EPS) of $5.71. In comparison to Q3 of the previous year, where net income was $55.4 million with an EPS of $7.76, this marks a notable shift.

The company's EBITDA stood at $63.3 million, indicating a significant drop from $91.8 million reported a year prior. Adjusted EBITDA followed closely, reflecting similar trends with figures of $63.9 million against $98.5 million in 2025. The total visits across the hospital division soared by 18.1% year-on-year, resulting in a total of 54,622 visits and a 12.4% increase at hospitals opened prior to 2025.

Detailed Nine-Month Review

For the nine months ending September 30, 2026, Nutex Health's net income rose to $152.9 million, marking an impressive 159% increase from $59.0 million reported in the same period in 2025. The diluted EPS for this period peaked at $21.50, compared to $8.87 a year ago. The cumulative EBITDA for the first three quarters reached $225.8 million, with adjusted figures approximating $211.4 million.

Despite the revenue fluctuation, total visits climbed to 154,326, with a 10.2% increase overall, and 6.3% growth in the same hospitals data.

Revenue Trends

Nutex Health faced a revenue decrease of 10.9% for the nine months, totaling $644.9 million against $723.6 million in 2025, with hospital division revenues for the same duration down 11.2%. This decline stems from the previous year’s favorable conditions which inflated estimates for services rendered.

The quarterly financials also reveal a steep revenue fall of 18.7% in Q3, totaling $217.6 million compared to $267.8 million in Q2 of the same fiscal year. Notably, the dip corresponds with adjustments to estimated collections and inconsistencies in billing records.

Operational Efficiency and Future Outlook

The efficiency of Nutex Health’s management is reflected in their cash operations, providing $188.1 million net cash from operating activities through the first three quarters. As of September 30, 2026, the company maintained total assets of $1 billion with cash equivalents totaling $249.9 million. Long-term debt increased slightly, amounting to $34.2 million against $29.2 million reported at year-end 2025.

Jon Bates, CFO of Nutex Health, noted, “2026 continues to show strong financial metrics with total revenues at $644.9 million and operating cash flow at $188.1 million.” He is optimistic about their strategy to expand, including the opening of two new hospital facilities by the end of Q4 2026.

Tom Vo, the Chairman and CEO, expressed satisfaction with patient volume growth across the organization and highlighted their robust pipeline for new hospitals, projecting a solid trajectory for growth and financial health moving forward.

Concluding Thoughts

Nutex Health's Q3 results for 2026 highlight both the challenges of fluctuating revenues and the promising growth trajectory. As the company ventures into new locations and bolsters its operations, stakeholders and investors will be keen to monitor its strategic developments and financial health in the upcoming quarters. Approved documents and reports are accessible via the U.S. Securities and Exchange Commission (SEC) for those interested in deeper insights into Nutex Health's financial performance.

Stay tuned for the upcoming conference call on November 6, 2026, at 9:30 AM CT, where company executives will further elaborate on these results and future projections.